El Granada, CA, United States of America

Paul A Sprengeler


Average Co-Inventor Count = 4.5

ph-index = 6

Forward Citations = 111(Granted Patents)


Location History:

  • Philadelphia, PA (US) (1993 - 2000)
  • Merion, PA (US) (2000)
  • El Granada, CA (US) (2001 - 2002)

Company Filing History:


Years Active: 1993-2002

Loading Chart...
15 patents (USPTO):Explore Patents

Title: **Inventor Profile: Paul A. Sprengeler**

Introduction

Paul A. Sprengeler is a notable inventor based in El Granada, California. With an impressive portfolio of 15 patents, Sprengeler has made significant contributions to the field of chemistry, particularly in the development of innovative therapeutic methods.

Latest Patents

Among his latest patents, Sprengeler has developed polypyrrolinone-based inhibitors of matrix metalloproteases. These non-peptide peptidomimetics are compounds that exhibit cross-reactivity with peptides, including those that bind to G-protein-linked receptors. The patents include preparative and therapeutic methods for utilizing these compounds, which possess a distinct general structure aimed at advancing medical applications.

Career Highlights

Throughout his career, Paul A. Sprengeler has worked at the University of Pennsylvania, where he has engaged in groundbreaking research that bridges the gap between chemistry and medicine. His innovative work has not only enhanced the understanding of biological processes but also opened new avenues for therapeutic developments.

Collaborations

Sprengeler's contributions to research have been strengthened through collaborations with esteemed colleagues, including Ralph F. Hirschmann and Amos B. Smith, III. These partnerships have facilitated a synergistic approach to advancing their collective research goals in the field.

Conclusion

In summary, Paul A. Sprengeler exemplifies the spirit of innovation through his extensive patent contributions and collaborative research efforts at the University of Pennsylvania. His work continues to impact the realms of biotechnology and pharmaceuticals, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…